News
08-27-2015, 10:00 AM
Use of the 21-gene recurrence test score was associated with lower chemotherapy use in high-risk patients and greater use of chemotherapy in low-risk patients compared with not using the test among...
More... (http://www.medicalnewstoday.com/releases/298684.php)
More... (http://www.medicalnewstoday.com/releases/298684.php)